July 13, 2017 / 8:17 AM / 9 days ago

BRIEF-Biohaven receives notice of allowance from U.S. Patent office on application for glutamate modulating prodrugs

1 Min Read

July 13 (Reuters) - Biohaven Pharmaceutical Holding Company Ltd:

* Biohaven receives notice of allowance from U.S. Patent and trademark office on patent application for glutamate modulating prodrugs Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below